Skip to content

Pulmonx Corporation LUNG Investment Proceeds

Investment Proceeds at other companies

Theravance Biopharma logo
Theravance BiopharmaTBPH
$96M+194%
Savara logo
SavaraSVRA
$13.13M-70.4%
United Therapeutics logo
United TherapeuticsUTHR
$1.31B
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$0-100%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$93.97M+422%
ResMed logo
ResMedRMD
$2.5M

Other financials

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Cash & equivalents$61.0M-2.4%
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation

See full
Market cap$54.91M-43.7%
Enterprise value$50.17M-39.2%
P/S0.6×-0.5×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
Net margin-60.1%-4.4pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×
Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulmonx Corporation's investment proceeds?
Pulmonx Corporation (LUNG) reported investment proceeds of $0 in Q1 2026.
How has Pulmonx Corporation's investment proceeds changed year-over-year?
Pulmonx Corporation's investment proceeds decreased by 100.0% year-over-year, from $20.54M to $0.
What is the long-term trend for Pulmonx Corporation's investment proceeds?
Over 4 years (2021 to 2025), Pulmonx Corporation's investment proceeds has grown at a 38.3% compound annual growth rate (CAGR), from $10M to $36.59M.
What does investment proceeds mean?
Cash received from sales, maturities, and redemptions of investment securities across all categories.